Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies

Gopalakrishnan, S; Menon, R; Suleiman, AA; Kater, AP; Stilgenbauer, S; Seymour, JF; Chyla, B; Lu, T; Young Kim, S; Roberts, AW; Woyach, JA; Mensing, S; Salem, AH

Author(s): Gopalakrishnan, S; Menon, R; Suleiman, AA; Kater, AP; Stilgenbauer, S; Seymour, JF; Chyla, B; Lu, T; Young Kim, S; Roberts, AW; Woyach, JA; Mensing, S; Salem, AH;
Details: Publication Year 2023-12,Volume 7,Issue #12,Page e983
Journal Title: HemaSphere
Publication Type: Review
Department(s): Clinical Haematology
Publisher's Version: https://doi.org/10.1097/hs9.0000000000000983
Open Access at Publisher's Site: https://doi.org/10.1097/hs9.0000000000000983
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2023-12-15 05:57:24

Last Modified: 2023-12-15 06:07:00